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Summary
Background:  Several  clinical  studies  have  demonstrated  an  inverse  relationship  between  systolic
blood pressure  (SBP)  at  admission  and  in-hospital  mortality  in  patients  hospitalized  for  acuteSystolic  blood
pressure;
Prognosis
myocardial infarction  (AMI).  However,  data  on  the  relation  between  admission  SBP  and  in-
hospital  prognosis  in  AMI  patients  are  still  lacking  in  Japan.
Methods  and  results:  A  total  of  1211  AMI  patients  were  classiﬁed  into  quintiles  based  on  SBP
at hospital  admission  (<106  mmHg,  n  =  241;  106—125  mmHg,  n  =  239;  126—140  mmHg,  n  =  244;
141—159 mmHg,  n  =  238;  and  ≥160  mmHg,  n  =  249).  The  patients  with  SBP  <106  mmHg  tended
to have  higher  age,  Killip  class  ≥3  at  admission,  right  coronary  artery,  left  main  trunk,
∗ Corresponding author. Tel.: +81 75 561 1121; fax: +81 75 561 6308.
E-mail address: risa11221998@yahoo.co.jp (J. Shiraishi).
1 On Behalf of the AMI-Kyoto Multi-Center Risk Study Group (see Appendix A).
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or  multivessels  as  culprit  lesions,  larger  number  of  diseased  vessels,  lower  Thrombolysis  In
Myocardial  Infarction  grade  in  the  infarct-related  artery  before  primary  percutaneous  coronary
intervention  (PCI),  and  higher  value  of  peak  creatine  phosphokinase  concentration.  Patients  with
SBP <106  mmHg  had  a  signiﬁcantly  higher  mortality,  while  mortality  was  not  signiﬁcantly  different
among the  other  quintiles:  25.7%  (<106  mmHg),  5.4%  (106—125  mmHg),  5.7%  (126—140  mmHg),
2.5% (141—159  mmHg),  and  5.6%  (≥160  mmHg)  (p  <  0.001).  On  multivariate  analysis,  Killip  class
≥3 at  admission,  admission  SBP  <106  mmHg,  and  age  were  the  independent  positive  predictors
of in-hospital  mortality,  whereas  admission  SBP  141—159  mmHg  and  primary  PCI  were  the  nega-
tive ones,  but  admission  SBP  106—125  mmHg,  admission  SBP  126—140  mmHg,  and  admission  SBP
≥160 mmHg  were  not.
Conclusions:  These  results  suggest  that  admission  SBP  141—159  mmHg  might  be  correlated  with
better in-hospital  prognosis,  whereas  admission  SBP  <106  mmHg  was  associated  with  in-hospital
death in  Japanese  patients  hospitalized  for  AMI.
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deﬁned  as  at  least  a  75%  reduction  in  the  internal  diameter
of  the  right,  left  anterior  descending,  or  left  circum-
ﬂex  coronary  arteries  and  their  major  branches,  or  a© 2011  Japanese  College  of  C
Introduction
Acute  myocardial  infarction  (AMI)  complicated  with  cardio-
genic  shock  is  a  condition  with  high  in-hospital  morbidity
and  mortality.  Several  reports  from  the  USA  and  European
investigators  have  shown  that  in  patients  with  AMI,  there
is  an  inverse  relationship  between  systolic  blood  pressure
(SBP)  at  admission  and  in-hospital  mortality,  and  SBP  at
admission  is  an  independent  predictor  of  in-hospital  death
[1—4].  Thus,  admission  SBP  is  regarded  as  one  useful  fac-
tor  for  early  risk  stratiﬁcation  in  AMI  patients  and  indeed
admission  SBP  is  involved  in  most  risk-scoring  methods
for  patients  with  AMI  [5—10]. However,  the  relationship
between  SBP  at  admission,  clinical  manifestations,  and
in-hospital  outcome  in  patients  hospitalized  for  AMI  has
not  been  fully  investigated  in  Japan.  The  AMI-Kyoto  Multi-
Center  Risk  Study,  a  large  multicenter  observational  study
in  which  collaborating  hospitals  in  Kyoto  Prefecture  have
collected  demographic,  procedural,  and  outcome  data  on
AMI  patients,  was  established  in  2000  in  order  to  analyze
these  data  and  establish  an  emergency-hospital  network  for
heart  diseases  in  Kyoto  [11—13]. The  purpose  of  the  present
study  was  therefore  to  examine  the  relationship  between
SBP  at  admission  and  in-hospital  prognosis  in  Japanese  AMI
patients,  using  data  from  the  AMI-Kyoto  Multi-Center  Risk
Study.
Methods
Patient  population
From  July  2006  to  December  2009,  1226  consecutive
patients  with  a  diagnosis  of  AMI,  who  were  admitted
to  AMI-Kyoto  Multi-Center  Risk  Study  Group  Hospitals
within  24  h  after  the  onset  of  AMI,  were  enrolled  in  the
present  study.  Of  these,  clinical  background  and  SBP  at
admission  were  available  in  1211  patients.  The  1211  AMI
patients  were  classiﬁed  into  quintiles  based  on  SBP  at
hospital  admission  (<106  mmHg,  n  =  241;  106—125  mmHg,
n  =  239;  126—140  mmHg,  n  =  244;  141—159  mmHg,  n  =  238;
and  ≥160  mmHg,  n  =  249).  Systolic  blood  pressure  at  admis-
sion  was  deﬁned  as  SBP  ﬁrst  recorded  in  supine  position
or  sitting  position  just  after  presentation  to  the  emer-
gency  room  or  the  outpatient  clinic.  We  retrospectively
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ompared  clinical  background,  coronary  risk  factors,  angio-
raphic  ﬁndings,  acute  results  of  primary  percutaneous
oronary  intervention  (PCI),  and  in-hospital  prognosis  among
he  5  groups.  The  diagnosis  of  AMI  required  the  presence  of  2
f  the  following  3  criteria:  (1)  characteristic  clinical  history;
2)  serial  changes  on  the  electrocardiogram  (ECG)  suggest-
ng  infarction  (Q-waves)  or  injury  (ST-segment  elevations);
nd  (3)  transient  increase  in  cardiac  enzymes  to  more  than
-fold  the  normal  laboratory  value.
ata  collection
he  patients’  demographic  information,  cardiovascular  his-
ory,  and  risk  factors  (i.e.  smoking,  hypercholesterolemia,
ypertension,  and  diabetes  mellitus)  were  recorded.  Hyper-
holesterolemia  was  deﬁned  as  total  cholesterol  ≥220  mg/dl
r  the  use  of  cholesterol-lowering  agents;  hypertension
as  deﬁned  as  systemic  blood  pressure  ≥140/90  mmHg
r  the  use  of  antihypertensive  treatment;  diabetes  mel-
itus  was  deﬁned  as  fasting  blood  sugar  ≥126  mg/dl  or
he  use  of  speciﬁc  treatment.  After  informed  consent
o  participate  in  the  AMI-Kyoto  Multi-Center  Risk  Study
as  conﬁrmed  by  each  patient,  all  in-hospital  data  were
ransmitted  to  the  center  located  at  the  Department  of
ardiology  and  Vascular  Regenerative  Medicine  in  Kyoto
refectural  University  School  of  Medicine  for  analysis.  The
tudy  protocol  was  approved  by  each  hospitals’  ethics
ommittee.
mergency  coronary  angiography  and  reperfusion
herapy
mergency  coronary  angiography  (CAG)  was  performed
sing  the  standard  technique.  The  coronary  ﬂow  in  the
nfarct-related  artery  (IRA)  was  graded  according  to  the
lassiﬁcation  used  in  the  Thrombolysis  In  Myocardial  Infarc-
ion  (TIMI)  trial.  Signiﬁcant  coronary  artery  stenosis  was0%  reduction  in  the  internal  diameter  of  the  left  main
runk  (LMT).  Non-signiﬁcant  stenosis  was  deﬁned  as  coro-
ary  arterial  narrowing  less  than  a  signiﬁcant  stenosis.
atients  with  either  angiographically  normal  coronary  arter-
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Table  1  Clinical  characteristics  by  systolic  blood  pressure  at  admission.
Systolic  blood  pressure  at  admission,  quintile,  mmHg  p-Value
<106  (n  =  241) 106—125
(n  =  239)
126—140
(n  =  244)
141—159
(n  =  238)
>160  (n  =  249)
Age  (mean  years  ±  SD)  70.6  ±  11.7  66.2  ±  13.0  68.6  ±  13.6  68.2  ±  12.2  67.3  ±  12.8  0.003
Male (%) 171  (71.0)  182  (76.2)  185  (75.8)  177  (74.4)  184  (73.9)  0.708
Previous myocardial  infarction  (%) 35 (14.5)  30 (12.6)  25 (10.2)  24  (10.1)  21  (8.4)  0.234
Risk factors
Smoking  (%) 94 (39.0)  103 (43.1)  113 (46.3)  100 (42.0)  84 (33.7)  0.056
Hypercholesterolemia  (%)  95  (39.4)  100  (41.8)  100  (41.0)  111  (46.6)  112  (45.0)  0.484
Hypertension  (%)  124  (51.5)  123  (51.5)  138  (56.6)  143  (60.1)  176  (70.7)  <0.001
Diabetes mellitus  (%)  76  (31.5)  63  (26.4)  57  (23.4)  72  (30.3)  89  (35.7)  0.029
Heart rate  at  admission  (bpm)  62.2  ±  30.0  72.4  ±  19.6  76.6  ±  19.4  79.1  ±  18.1  83.8  ±  20.2  <0.001
Killip 3/4  (%)  95  (39.4)  18  (7.5)  20  (8.2)  20  (8.4)  25  (10.0)  <0.001
Data on admission heart rate were available in 234 of the 241 patients with SBP <106 mmHg, 235 of the 239 patients with SBP
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I106—125 mmHg, 238 of the 244 patients with SBP 126—140 mmH
249 patients with SBP ≥160 mmHg.
es  or  non-signiﬁcant  stenosis  were  classiﬁed  as  having
ero-vessel  disease.  Multivessels  as  culprit  lesions  were
eﬁned  as  simultaneous  thromboses  of  multiple  coronary
rteries  in  the  initial  CAG.  After  the  culprit  lesions  were
scertained  by  CAG,  primary  PCI  was  subsequently  per-
ormed.
ndpoint  measures
n-hospital  death  was  deﬁned  as  all-cause  death  during
dmission  period.
tatistics
ata  are  expressed  as  mean  ±  SD.  Five  groups  were  com-
ared  using  the  chi-square  test  for  discrete  variables  and
-way  analysis  of  variance  (ANOVA),  followed  by  Scheffe’s
est  as  the  post-hoc  test  for  continuous  variables  according
o  standard  statistical  methods.  The  odds  ratio  and  95%  con-
dence  intervals  assessing  the  risk  of  in-hospital  death  were
stimated  by  use  of  multivariate  logistic  regression  analy-
is.  In  all  analyses,  statistical  signiﬁcance  was  accepted  at
 <  0.05.
esults
atient  characteristics  and  risk  factors
he  clinical  characteristics  and  risk  factors  among  the  5
roups  are  summarized  in  Table  1.  Age,  heart  rate  at  admis-
ion,  and  frequency  of  hypertension,  diabetes  mellitus,
nd  Killip  class  ≥3  at  admission  were  signiﬁcantly  differ-
nt  among  the  5  groups.  The  patients  with  SBP  <106  mmHg
ad  higher  age,  lower  heart  rate,  and  larger  prevalence  of
illip  class  ≥3  at  admission,  while  the  patients  with  SBP
160  mmHg  had  higher  frequency  of  hypertension  and  dia-
etes  mellitus.
T
T
a4 of the 238 patients with SBP 141—159 mmHg, and 242 of the
ngiographic  data
able  2  shows  the  emergency  CAG  data  for  the  5  groups.
revalence  of  emergency  CAG  was  not  signiﬁcantly  differ-
nt  among  the  5  groups.  In  the  1170  AMI  patients  undergoing
mergency  CAG,  the  distribution  of  culprit  coronary  artery
nd  the  number  of  diseased  vessels  were  signiﬁcantly  differ-
nt  among  the  5  groups.  The  patients  with  SBP  <106  mmHg
ere  more  likely  to  have  right  coronary  artery  (RCA),  LMT,
r  multivessel  disease  as  culprit  lesions  as  well  as  larger
umber  of  diseased  vessels  or  diseased  LMT  on  initial  CAG.
esults  of  coronary  intervention
able  3  shows  the  results  of  primary  PCI  in  the  5  groups.
fter  CAG,  PCI  was  subsequently  performed  in  224  of  the
atients  with  SBP  <106  mmHg  (93%),  215  of  the  patients
ith  SBP  106—125  mmHg  (90%),  228  of  the  patients  with
BP  126—140  mmHg  (93%),  221  of  the  patients  with  SBP
41—159  mmHg  (93%),  and  216  of  the  patients  with  SBP
160  mmHg  (87%).  The  frequency  of  primary  PCI  was  signiﬁ-
antly  different  among  the  5  groups.  Data  on  TIMI  grade  were
vailable  in  221  of  the  224  patients  with  SBP  <106  mmHg,  213
f  the  215  patients  with  SBP  106—125  mmHg,  223  of  the  228
atients  with  SBP  126—140  mmHg,  216  of  the  221  patients
ith  SBP  141—159  mmHg,  and  213  of  the  216  patients  with
BP  ≥160  mmHg.  The  distribution  of  TIMI  grade  in  the  IRA
efore  primary  PCI  was  signiﬁcantly  different  among  the  5
roups.  The  patients  with  SBP  <106  mmHg  tended  to  have
ower  TIMI  grade  in  the  IRA  before  primary  PCI  and  higher
requency  of  intra-aortic  balloon  pumping,  percutaneous
ardiopulmonary  support,  and  temporary  pacing  during  pro-
edures  and/or  admission  period.
n-hospital  outcomesable  4  shows  the  in-hospital  prognoses  in  the  5  groups.
he  patients  with  lower  admission  SBP  were  likely  to  have
 higher  value  of  peak  creatine  phosphokinase  (CK)  concen-
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Table  2  Angiographic  ﬁndings  by  systolic  blood  pressure  at  admission.
Systolic  blood  pressure  at  admission  quintile,  mmHg  p-Value
<106  (n  =  241) 106—125  (n  =  239)  126—140  (n  =  244)  141—159  (n  =  238)  >160  (n  =  249)
Emergency  CAG  (%)  232  (96.3)  228  (95.4)  239  (98.0)  230  (96.6)  241  (96.8)  0.640
Culprit lesions
None  (%) 2 (0.9)  1  (0.4)  0  (0.0)  2  (0.9)  1  (0.4)  <0.001
RCA (%) 117 (50.4)  95 (41.7)  73 (30.5)  74 (32.2)  38  (15.8)
LAD (%) 58 (25.0)  90 (39.5)  119 (49.8)  112 (48.7)  154 (63.9)
LCx (%) 19 (8.2)  33 (14.5)  35 (14.6)  34 (14.8)  39 (16.2)
LMT (%)  20  (8.6)  2  (0.9)  2  (0.8)  4  (1.7)  4  (1.7)
Multivessels (%)  15  (6.5)  7  (2.9)  9  (3.8)  4  (1.7)  5  (2.1)
SVG 1  (0.4)  0  (0.0)  1  (0.4)  0  (0.0)  0  (0.0)
No. of  diseased  vessels
0  (%)  2  (0.9)  1  (0.4)  1  (0.4)  2  (0.9)  2  (0.8)  <0.001
1 (%)  110  (47.4)  142  (62.3)  138  (57.7)  133  (57.8)  151  (62.7)
2 (%)  61  (26.3)  58  (25.4)  67  (28.0)  67  (29.1)  57  (23.7)
3 (%)  39  (16.8)  25  (11.0)  31  (13.0)  24  (10.4)  27  (11.2)
LMT (%)  20  (8.6)  2  (0.9)  2  (0.8)  4  (1.7)  4  (1.7)
t ant
o
w
c
a
a
i
sCAG, coronary angiography; RCA, right coronary artery; LAD, lef
artery; LMT, left main trunk; SVG, saphenous vein graft.
tration.  Patients  with  SBP  <106  mmHg  had  a  signiﬁcantly
higher  mortality,  while  mortality  was  not  signiﬁcantly
different  among  the  other  quintiles:  25.7%  (<106  mmHg),
5.4%  (106—125  mmHg),  5.7%  (126—140  mmHg),  2.5%
(141—159  mmHg),  and  5.6%  (≥160  mmHg)  (p  <  0.001).  The
SBP-associated  trends  in  cardiac-related  death  coincided
with  that  in  overall  death.  Death  ascribed  to  cardiogenic
shock,  congestive  heart  failure,  and  ventricular  ﬁbrillation
was  common  in  the  patients  with  SBP  <106  mmHg,  while
death  associated  with  ventricular  rupture  was  frequent  not
p
1
a
Table  3  Results  of  coronary  intervention  by  systolic  blood  pressu
Systolic  blood  pressure  at  admission,  quintile,  m
<106  (n  =  241)  106—125  (n  =  239)  126—14
Primary  PCI  (%)  224  (92.9)  215  (90.0)  228  (
Pre TIMI  grade
0 149  (67.4)  127  (59.6)  121  (
1 35  (15.8)  23  (10.8)  29  (
2 14  (6.3)  34  (16.0)  41  (
3 23 (10.4)  29  (13.6)  32  (
Post TIMI  grade
0 5  (2.3)  1  (0.5)  2  (
1 5 (2.3) 6  (2.8)  3  (
2 18 (8.1) 13 (6.1)  11  (
3 193  (87.3)  193  (90.6)  207  (
Stent (%)  197  (87.9)  188  (87.4)  203  (
IABP (%)  71  (29.5)  28  (11.7)  27  (
PCPS(%) 20  (8.3)  0  (0.0)  1  (
Pacing (%)  59  (24.5)  18  (7.5)  13  (
PCI indicates percutaneous coronary intervention; TIMI, thrombolysis in
percutaneous cardiopulmonary support. Data on TIMI grade available 
patients with SBP 106—125 mmHg, 223 of the 228 patients with SBP 12
and 213 of the 216 patients with SBP ≥160 mmHg.erior descending coronary artery; LCx, left circumﬂex coronary
nly  in  the  patients  with  lower  SBP  but  also  in  the  patients
ith  SBP  ≥160  mmHg.  In  order  to  assess  the  contribution  of
linical  background,  risk  factors,  primary  PCI,  and  SBP  at
dmission,  a  multivariate  logistic  regression  analysis  using
ll  available  variables  (age,  gender,  previous  myocardial
nfarction,  smoking,  hypercholesterolemia,  hyperten-
ion,  diabetes  mellitus,  Killip  class  ≥3  at  admission,
rimary  PCI,  and  SBP  <106  mmHg,  SBP  106—125  mmHg,  SBP
26—140  mmHg,  SBP  141—159  mmHg,  or  SBP  ≥160  mmHg
t  admission)  was  developed  for  overall  death  during
re  at  admission.
mHg  p-Value
0  (n  =  244)  141—159  (n  =  238)  >160  (n  =  249)
93.4)  221  (92.9)  216  (86.7)  0.043
54.3)  133  (61.6)  109  (51.2)  0.001
13.0)  20  (9.3)  23  (10.8)
18.4)  30  (13.9)  39  (18.3)
14.3)  33  (15.3)  42  (19.7)
0.9)  6  (2.8)  2  (0.9)  0.075
1.3)  1  (0.5)  0  (0.0)
4.9)  15  (6.9)  8  (3.8)
92.8)  194  (89.8)  203  (95.3)
89.0)  189  (85.5)  183  (84.7)  0.652
11.1)  23  (9.7)  24  (9.6)  <0.001
0.4)  0  (0.0)  1  (0.4)  <0.001
5.3)  11  (4.6)  1  (0.4)  <0.001
 myocardial infarction; IABP, intra-aortic balloon pumping; PCPS,
in 221 of the 224 patients with SBP <106 mmHg, 213 of the 215
6—140 mmHg, 216 of the 221 patients with SBP 141—159 mmHg,
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Table  4  In-hospital  outcomes  by  systolic  blood  pressure  at  admission.
Systolic  blood  pressure  at  admission,  quintile,  mmHg  p-Value
<106  (n  =  241) 106—125  (n  =  239)  126—140  (n  =  244)  141—159  (n  =  238)  >160  (n  =  249)
Peak  CK  (IU/l)  4439.2  ±  7316.1  2917.7  ±  2514.5  2730.7  ±  2431.0  2435.9  ±  2175.0  2359.7  ±  2472.2  <0.001
Death (%)  62  (25.7)  13  (5.4)  14  (5.7)  6  (2.5)  14  (5.6)  <0.001
Cardiac-
related (%)
42  (17.4)  11  (4.6)  10  (4.1)  3  (1.3)  9  (3.6)  <0.001
Shock 25 5 5 3 3
Heart failure 11 2 4 0 1
Rupture  3  4  1  0  4
Vf 3  0  0  0  1
Noncardiac-
related
(%)
20 (8.3)  2  (0.8)  4  (1.6)  3  (1.3)  5  (2.0)  <0.001
Data on peak CK available in 227 of the 241 patients with SBP <106 mmHg, 234 of the 239 patients with SBP 106—125 mmHg, 242 of the 244
P 141—159 mmHg, and 236 of the 249 patients with SBP ≥160 mmHg.
lic blood pressure.
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higher  value  of  peak  CK  concentration,  and  a  signiﬁcantly
higher  in-hospital  mortality  rate.  However,  inconsistent  with
the  reports  from  the  US  and  European  investigators,  the
patients  with  admission  SBP  141—159  mmHg  might  have
better  in-hospital  outcome  among  Japanese  patients  with
AMI.
Table  5  Predictors  of  in-hospital  mortality  in  the  study
patients  (multivariate  logistic  regression  analysis).  (A)
Admission  SBP  <106  mmHg  was  included  as  a  variable  and  (B)
admission  SBP  141—159  mmHg  was  included  as  a  variable.
OR 95%  CI p-Value
A
Killip  3/4 10.329  6.287—16.969  <0.0001
SBP <106  mmHg 3.969  2.391—6.587  <0.0001
Age 1.045  1.020—1.070  0.0003
Primary  PCI  0.391  0.203—0.755  0.0051
Smoking 0.544  0.294—1.009  0.0534
Hypercholesterolemia 0.619  0.360—1.049  0.0744
Hypertension 1.026  0.619—1.702  0.9198
Diabetes  mellitus  1.036  0.623—1.723  0.8908
Male 0.639  0.380—1.074  0.0908
Previous  MI  0.737  0.351—1.544  0.4182
B
Killip 3/4  15.681  9.735—25.260  <0.0001
SBP 141—159  mmHg  0.204  0.080—0.520  0.0009
Age 1.044  1.021—1.069  0.0002
Primary  PCI  0.465  0.243—0.892  0.0211
Smoking  0.576  0.316—1.051  0.0722
Hypercholesterolemia 0.589  0.346—1.001  0.0505
Hypertension 0.918  0.561—1.504  0.7349
Diabetes  mellitus 1.021  0.619—1.686  0.9342
Male 0.643  0.385—1.076  0.0928patients with SBP 126—140 mmHg, 235 of the 238 patients with SB
CK, creatine phosphokinase; Vf, ventricular ﬁbrillation; SBP, systo
ospitalization.  On  multivariate  analysis,  Killip  class  ≥3  at
dmission,  age,  and  admission  SBP  <106  mmHg  were  the
ndependent  positive  predictors  of  in-hospital  mortality,
hereas  primary  PCI  and  admission  SBP  141—159  mmHg
ere  the  negative  ones  (Table  5A  and  B).  In  contrast,
dmission  SBP  106—125  mmHg  (odds  ratio  [OR]  0.816,
5%  conﬁdence  intervals  [CI]  0.408—1.632),  admission
BP  126—140  mmHg  (OR  0.769,  95%  CI  0.396—1.495),
nd  admission  SBP  ≥160  mmHg  (OR  0.567,  95%  CI
.284—1.131)  were  not  tightly  associated  with  in-hospital
eath.
iscussion
he  major  ﬁndings  of  the  present  multicenter  study
re  as  follows:  among  AMI  patients,  patients  with  SBP
106  mmHg  had  a  signiﬁcantly  higher  mortality,  while  mor-
ality  was  not  signiﬁcantly  different  among  the  other
uintiles:  25.7%  (<106  mmHg),  5.4%  (106—125  mmHg),
.7%  (126—140  mmHg),  2.5%  (141—159  mmHg),  and  5.6%
≥160  mmHg)  (p  <  0.001);  on  multivariate  analysis,  Killip
lass  ≥3  at  admission,  age,  and  SBP  <106  mmHg  at  admis-
ion  were  the  independent  positive  predictors  of  in-hospital
eath,  whereas  primary  PCI  and  SBP  141—159  mmHg  at
dmission  were  the  negative  ones,  but  admission  SBP
06—125  mmHg,  admission  SBP  126—140  mmHg,  and  admis-
ion  SBP  ≥160  mmHg  were  not.
This  study  is  the  ﬁrst  to  investigate  the  effects  of  SBP
t  admission  on  in-hospital  prognosis  among  AMI  patients
n  Japan.  Previous  studies  in  Western  countries  have  shown
hat  the  higher  the  SBP  is  at  admission,  the  better  the  prog-
osis  of  AMI  patients  [1—4]. Since  SBP  is  considered  to  reﬂect
 combination  of  cardiac  output  and  systemic  peripheral
esistance,  higher  SBP  at  admission  might  indicate  not  only
n  enhanced  systemic  resistance  but  also  a  preserved  car-
iac  function  with  less  myocardial  damage  in  patients  with
MI.  In  the  present  report,  the  patients  with  SBP  <106  mmHg
ended  to  have  Killip  class  ≥3  at  admission,  RCA,  LMT,  or
ultivessels  as  culprit  lesions,  larger  number  of  diseased
essels,  lower  TIMI  grade  in  the  IRA  before  primary  PCI,
Previous  MI 0.887  0.433—1.817  0.7440
OR, odds ratio; CI, conﬁdence intervals; SBP, systolic blood pres-
sure; PCI, percutaneous coronary intervention; MI, myocardial
infarction.
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The  mechanism  for  which  admission  SBP  141—159  mmHg,
not  admission  SBP  ≥160  mmHg,  was  associated  with  better
in-hospital  outcome  remains  uncertain.  Based  on  the  value
of  peak  CK,  the  extent  of  myocardial  damage  was  inversely
correlated  with  admission  SBP,  and  indeed  prevalence  of
in-hospital  deaths  due  to  shock  or  heart  failure  was  also
almost  inversely  correlated  with  admission  SBP.  In  contrast,
no  deaths  ascribed  to  ventricular  rupture  were  observed  in
the  patients  with  SBP  141—159  mmHg,  while  the  rupture-
related  death  was  more  frequent  in  the  patients  with  SBP
≥160  mmHg  as  well  as  in  the  patients  with  lower  SBP.  Hyper-
tension,  advanced  age,  female  gender,  lower  body  mass
index,  delayed  reperfusion,  ﬁrst  AMI,  1-vessel  disease  with
preserved  left  ventricular  function,  totally  occluded  left
anterior  descending  coronary  artery  as  culprit,  and  small
myocardial  infarction  due  to  branch  occlusion  have  been
reported  to  be  associated  with  cardiac  rupture  [14—16]. In
the  present  study,  the  patients  with  SBP  ≥160  mmHg  char-
acterized  by  smaller  peak  CK  as  well  as  higher  prevalence
of  hypertension,  ﬁrst  AMI,  left  anterior  descending  coro-
nary  artery  as  culprit,  and  1-vessel  disease,  might  therefore
be  at  high  risk  of  ventricular  rupture  and  increased  cardiac
deaths  due  to  ventricular  rupture  might  contribute  in  part
to  a  relatively  high  in-hospital  mortality  in  the  patients  with
admission  SBP  ≥160  mmHg.
Another  possible  explanation  is  that  lesser  frequency  of
primary  PCI  might  account  for  a  relatively  high  in-hospital
mortality  in  the  patients  with  admission  SBP  ≥160  mmHg.
Indeed,  based  on  the  multivariate  analysis,  undergoing  pri-
mary  PCI  is  a  negative  predictor  of  in-hospital  death  in
the  present  report.  However,  since  frequency  of  emergency
CAG  was  not  signiﬁcantly  different  among  the  5  groups,
higher  prevalence  of  TIMI  3  ﬂow  before  PCI  might  con-
tribute  to  lesser  frequency  of  primary  PCI  in  the  patients
with  admission  SBP  ≥160  mmHg.  To  the  contrary,  not  only
lesser  prevalence  of  the  in-hospital  deaths  due  to  shock  or
heart  failure  but  also  the  absence  of  death  ascribed  to  ven-
tricular  rupture  might  result  in  a  low  in-hospital  mortality
in  the  patients  with  admission  SBP  141—159  mmHg.
Early  risk  stratiﬁcation  is  indispensable  for  optimal
emergency  treatment  in  patients  with  AMI.  A  number  of
risk-scoring  methods  have  been  proposed  by  US  and  Euro-
pean  investigators,  and  several  factors  such  as  clinical
presentation  (cardiac  arrest  at  arrival),  gender,  age,  SBP,
heart  rate,  Killip  class,  renal  function,  ST  deviation,  QRS
duration,  anterior  myocardial  infarction,  cardiac  enzyme
elevation,  and/or  cardiovascular  risk  were  involved  in  those
risk  scores  [5—10]. Hyperglycemia  and  leukocytosis  during
acute  phase  as  well  as  increased  heart  rate  on  admis-
sion  have  also  been  reported  to  be  associated  with  poor
in-hospital  clinical  outcome  in  AMI  patients  [17,18].  Accu-
mulating  evidence  has  demonstrated  an  inverse  relation
between  SBP  and  in-hospital  prognosis  in  AMI  patients,  and
SBP  has  been  therefore  regarded  as  a  major  component  in
those  risk-scoring  systems.  However,  detailed  data  regarding
relationship  between  admission  SBP  and  prognosis  are  still
lacking  in  Japan,  and  a  prognostic  risk-scoring  system  has  not
yet  been  established  for  Japanese  patients  with  AMI.  Further
prospective  and  long-term  follow-up  studies  are  necessary
to  elucidate  the  effects  of  admission  SBP  on  prognosis  and
to  produce  a  prognostic  risk  assessment  system  in  Japanese
patients  with  AMI.59
tudy  limitations
irst,  this  is  a  retrospective  observational  analysis  of  a
elatively  small  number  of  patients.  Second,  data  on  clin-
cal  background  and  angiographic  results  of  primary  PCI
ere  not  available  for  all  AMI  patients.  Third,  we  did
ot  have  enough  data  regarding  left  ventricular  function,
eart  rate  at  admission,  and  in-hospital  medical  treatment,
hich  might  predict  risk  of  in-hospital  death.  Fourth,  ‘‘ST-
levation  MI’’  was  not  discriminated  from  ‘‘non-ST-elevation
I’’.
onclusion
he  present  study  suggests  that  among  Japanese  AMI
atients,  admission  SBP  141—159  mmHg  might  be  correlated
ith  better  in-hospital  prognosis,  whereas  admission  SBP
106  mmHg  was  associated  with  in-hospital  death.  However,
he  relatively  small  size  of  the  study  population  as  well  as
he  lack  of  data  regarding  left  ventricular  function  are  major
imitations,  so  a  larger  and  more  detailed  study  should  be
erformed  to  conﬁrm  our  ﬁndings.
ppendix A.
he  following  institutions  and  principal  investigators  partic-
pated  in  the  present  study  as  the  AMI-Kyoto  Multi-Center
isk  Study  Group:  Kyoto  City  Hospital:  Okada  T,  Shima  M,
iyama  M,  Takamiya  A,  Nakajima  N;  Kyoto  Kidugawa  Hospi-
al:  Miyanaga  H,  Nakagawa  T,  Matsui  H,  Kunieda  Y;  Kyoto
econd  Red  Cross  Hospital:  Fujita  H,  Inoue  K,  Matsuo  A,
akatani  T,  Tsubakimoto  Y;  Social  Insurance  Kyoto  Hospi-
al:  Yamada  C,  Oda  Y,  Tanabe  S;  Tanabe  Central  Hospital:
usuoka  S,  Takechi  N,  Nishizawa  S;  Nantan  General  Hospital:
atsumi  T,  Keira  N,  Nishikawa  S,  Nomura  T;  Ayabe  Munic-
pal  Hospital:  Shiga  K,  Kohno  Y,  Yokoi  H;  Maizuru  Medical
enter:  Harada  Y,  Hikosaka  T,  Nakagami  T;  Kyoto  Saiseikai
ospital:  Yamahara  Y,  Ishibashi  K,  Takeda  M;  Gakkentoshi
ospital:  Sakai  R,  Akashi  K;  Kouseikai  Takeda  Hospital:  Mat-
umoto  K,  Kinoshita  N,  Nakamura  R;  Kameoka  Municipal
ospital:  Matsuo  R;  Aiseikai  Yamashina  Hospital:  Yamamoto
;  Fukuchiyama  Municipal  Hospital:  Nishio  M,  Sakamoto  T,
atsunaga  S;  Kyoto  Prefectural  Yosanoumi  Hospital:  Kimura
,  Isodono  K,  Honsho  S,  Tagawa  M;  Kyoto  Prefectural  Univer-
ity  School  of  Medicine:  Shiraishi  H,  Yamano  T.
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